Menu
GeneBe

3-52401844-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004656.4(BAP1):c.*444C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0381 in 292,396 control chromosomes in the GnomAD database, including 284 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.036 ( 143 hom., cov: 33)
Exomes 𝑓: 0.040 ( 141 hom. )

Consequence

BAP1
NM_004656.4 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.271
Variant links:
Genes affected
BAP1 (HGNC:950): (BRCA1 associated protein 1) This gene belongs to the ubiquitin C-terminal hydrolase subfamily of deubiquitinating enzymes that are involved in the removal of ubiquitin from proteins. The encoded enzyme binds to the breast cancer type 1 susceptibility protein (BRCA1) via the RING finger domain of the latter and acts as a tumor suppressor. In addition, the enzyme may be involved in regulation of transcription, regulation of cell cycle and growth, response to DNA damage and chromatin dynamics. Germline mutations in this gene may be associated with tumor predisposition syndrome (TPDS), which involves increased risk of cancers including malignant mesothelioma, uveal melanoma and cutaneous melanoma. [provided by RefSeq, May 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 3-52401844-G-A is Benign according to our data. Variant chr3-52401844-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 346111.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0361 (5493/152308) while in subpopulation NFE AF= 0.0497 (3377/68012). AF 95% confidence interval is 0.0483. There are 143 homozygotes in gnomad4. There are 2529 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd at 5492 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
BAP1NM_004656.4 linkuse as main transcriptc.*444C>T 3_prime_UTR_variant 17/17 ENST00000460680.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
BAP1ENST00000460680.6 linkuse as main transcriptc.*444C>T 3_prime_UTR_variant 17/171 NM_004656.4 P1

Frequencies

GnomAD3 genomes
AF:
0.0361
AC:
5492
AN:
152190
Hom.:
142
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0139
Gnomad AMI
AF:
0.0866
Gnomad AMR
AF:
0.0470
Gnomad ASJ
AF:
0.0300
Gnomad EAS
AF:
0.0217
Gnomad SAS
AF:
0.0215
Gnomad FIN
AF:
0.0301
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0496
Gnomad OTH
AF:
0.0421
GnomAD4 exome
AF:
0.0402
AC:
5638
AN:
140088
Hom.:
141
Cov.:
0
AF XY:
0.0396
AC XY:
2709
AN XY:
68426
show subpopulations
Gnomad4 AFR exome
AF:
0.0150
Gnomad4 AMR exome
AF:
0.0435
Gnomad4 ASJ exome
AF:
0.0310
Gnomad4 EAS exome
AF:
0.0150
Gnomad4 SAS exome
AF:
0.0157
Gnomad4 FIN exome
AF:
0.0261
Gnomad4 NFE exome
AF:
0.0489
Gnomad4 OTH exome
AF:
0.0504
GnomAD4 genome
AF:
0.0361
AC:
5493
AN:
152308
Hom.:
143
Cov.:
33
AF XY:
0.0340
AC XY:
2529
AN XY:
74482
show subpopulations
Gnomad4 AFR
AF:
0.0138
Gnomad4 AMR
AF:
0.0470
Gnomad4 ASJ
AF:
0.0300
Gnomad4 EAS
AF:
0.0214
Gnomad4 SAS
AF:
0.0213
Gnomad4 FIN
AF:
0.0301
Gnomad4 NFE
AF:
0.0497
Gnomad4 OTH
AF:
0.0440
Alfa
AF:
0.0493
Hom.:
208
Bravo
AF:
0.0371
Asia WGS
AF:
0.0350
AC:
122
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

BAP1-related tumor predisposition syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxJun 15, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
Cadd
Benign
0.80
Dann
Benign
0.27
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs123598; hg19: chr3-52435860; API